ENTHEON BIOMEDICAL CORP To Carry Out 1-for-10 Reverse Stock Split On March 1st, 2024

February 29th - $ENTHEON BIOMEDICAL CORP(ENTBF.US)$ is about to implement a 1-for-10 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from March 1st, 2024.$ENTHEO

Futu NewsFeb 29 08:40

RBC Downgrades Nevro to Sector Perform, Cites Salesforce Turnaround

Seeking AlphaJan 13 00:01

Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders

PR NewswireJul 27, 2022 20:51

Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill

Benzinga Real-time NewsJun 16, 2022 00:35

Cybin to acquire DMT clinical study from Entheon Biomedical

Seeking AlphaJun 7, 2022 20:28

Ehave Partners With Halugen Life Sciences To Create A Ketamine Precision Medicine Platform For Clinical Research

Benzinga Real-time NewsJun 2, 2022 04:35